In addition, TCF19 levels have been associated with the risk of head and neck cancer (38) and it has proven prognostic potential for colorectal cancer [13], renal clear cell carcinoma [42], endometrial cancer [22] and hepatocellular carcinoma [43] patients. This evidence concerns the gene TCF19 and hepatocellular carcinoma.